Current global health developments include China's green light for foreign-owned hospitals, the addition of AstraZeneca's ...
AstraZeneca and Daiichi Sankyo’s breast cancer drug Enhertu to join China’s state health insurance in 2025, enhancing ...
The new 1.1 billion-yuan ($152 million) production facility in Shanghai will make antibody-drug conjugates, which use ...
China: Enhertu, a blockbuster breast cancer drug of AstraZeneca, will be included in China's state-run health insurance ...
The U.S. pharmaceutical industry seeks to alter Medicare drug price negotiation laws under Trump's return. China approves ...
which was cleared in China for TNBC in 2022. The approval means Kelun has brought its TROP2 ADC to market ahead of ...
The first company to take up residence in Bayer Co.Lab Berlin – initially located on the group's pharma headquarters site in ...
Request To Download Sample of This Strategic Report @ Rising cases of thyroid cancer is expected to drive the market. According to National Cancer Institute about 1.2% of men and women are detected ...
The report claims that Europe 's airports generate 14 million jobs and EUR851 billion in GDP (being 5% of the entire European ...
The Canadian Press on MSN6h
Today-History-Dec08Today in History for Dec. 8: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback